EndoChoice Holdings Company Profile (NYSE:GI)

About EndoChoice Holdings (NYSE:GI)

EndoChoice Holdings logoEndoChoice Holdings, Inc. is a medical device company. The Company is focused on designing and commercializing a platform of products and services for gastrointestinal (GI) caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems. The Company's products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD). The Company's imaging products include Fuse system, EndoCart, and Endoscope repair and maintenance. The Company's single-use therapeutic devices include Neptune injection needle, Boa polypectomy snare, Rescue retrieval devices, Blox bite block, TrapEase polyp traps, Hydra irrigation system, EndoGlide+, Compliance EndoKit, SafeStart, EndoKit, CinchPad and GI pathology. The Company serves over 2,500 GI departments that perform endoscopic procedures.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Symbol: NYSE:GI
  • CUSIP: N/A
  • Web: www.endochoice.com
Average Prices:
  • 50 Day Moving Avg: $8.00
  • 200 Day Moving Avg: $7.14
  • 52 Week Range: $3.64 - $8.03
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.35
  • P/E Growth: 0.00
Profitability:
  • Net Margins: -95.68%
  • Return on Equity: -83.69%
  • Return on Assets: -45.04%
Debt:
  • Debt-to-Equity Ratio: 0.93%
  • Current Ratio: 3.95%
  • Quick Ratio: 3.09%
Misc:
  • Beta: 1.13
 

Frequently Asked Questions for EndoChoice Holdings (NYSE:GI)

What is EndoChoice Holdings' stock symbol?

EndoChoice Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "GI."

How were EndoChoice Holdings' earnings last quarter?

EndoChoice Holdings Inc (NYSE:GI) issued its earnings results on Wednesday, May, 4th. The company reported ($0.68) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by $0.13. The firm earned $18.46 million during the quarter, compared to analysts' expectations of $18.34 million. EndoChoice Holdings had a negative net margin of 95.68% and a negative return on equity of 83.69%. The business's revenue for the quarter was up 10.2% compared to the same quarter last year. During the same quarter last year, the firm earned ($1.00) EPS. View EndoChoice Holdings' Earnings History.

Where is EndoChoice Holdings' stock going? Where will EndoChoice Holdings' stock price be in 2017?

3 analysts have issued 1 year target prices for EndoChoice Holdings' shares. Their forecasts range from $7.00 to $7.00. On average, they anticipate EndoChoice Holdings' share price to reach $7.00 in the next year. View Analyst Ratings for EndoChoice Holdings.

Who are some of EndoChoice Holdings' key competitors?

When did EndoChoice Holdings IPO?

(GI) raised $101 million in an IPO on Friday, June 5th 2015. The company issued 6,300,000 shares at $15.00-$17.00 per share. J.P. Morgan, BofA Merrill Lynch, William Blair and Stifel served as the underwriters for the IPO.

How do I buy EndoChoice Holdings stock?

Shares of EndoChoice Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of EndoChoice Holdings stock cost?

One share of EndoChoice Holdings stock can currently be purchased for approximately $8.00.

Analyst Ratings

Consensus Ratings for EndoChoice Holdings (NYSE:GI) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $7.00 (12.50% downside)

Analysts' Ratings History for EndoChoice Holdings (NYSE:GI)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/30/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
8/4/2016Stifel NicolausLower Price TargetBuy$10.00 -> $7.00N/AView Rating Details
8/4/2016JPMorgan Chase & Co.DowngradeOverweight -> NeutralN/AView Rating Details
3/24/2016Bank of America CorpDowngradeNeutral -> Underperform$10.00N/AView Rating Details
(Data available from 5/26/2015 forward)

Earnings

Earnings History for EndoChoice Holdings (NYSE:GI)
Earnings by Quarter for EndoChoice Holdings (NYSE:GI)
Earnings History by Quarter for EndoChoice Holdings (NYSE:GI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2016Q116($0.55)($0.68)$18.34 million$18.46 millionViewN/AView Earnings Details
3/3/2016Q415($0.58)($0.53)$19.05 million$18.50 millionViewN/AView Earnings Details
11/5/2015Q315($0.54)($0.47)$18.42 million$18.40 millionViewN/AView Earnings Details
8/6/2015Q215($0.85)($0.60)$17.59 million$18.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for EndoChoice Holdings (NYSE:GI)
2017 EPS Consensus Estimate: ($2.00)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.57)($0.57)($0.57)
Q2 20171($0.55)($0.55)($0.55)
Q3 20171($0.48)($0.48)($0.48)
Q4 20171($0.40)($0.40)($0.40)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for EndoChoice Holdings (NYSE:GI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for EndoChoice Holdings (NYSE:GI)
Insider Ownership Percentage: 31.50%
Institutional Ownership Percentage: 37.32%
Insider Trades by Quarter for EndoChoice Holdings (NYSE:GI)
Institutional Ownership by Quarter for EndoChoice Holdings (NYSE:GI)
Insider Trades by Quarter for EndoChoice Holdings (NYSE:GI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/16/2016Mark GilreathCEOBuy20,000$5.06$101,200.00View SEC Filing  
3/15/2016Mark GilreathCEOBuy5,018$5.02$25,190.36View SEC Filing  
3/11/2016David L KaufmanDirectorBuy89,450$4.81$430,254.50View SEC Filing  
3/10/2016David N GillCFOBuy2,000$4.70$9,400.00View SEC Filing  
3/10/2016William R EnquistDirectorBuy10,000$4.74$47,400.00View SEC Filing  
3/8/2016J Scott CarterDirectorBuy21,600$4.72$101,952.00View SEC Filing  
3/7/2016David N GillCFOBuy5,000$4.77$23,850.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for EndoChoice Holdings (NYSE:GI)
Latest Headlines for EndoChoice Holdings (NYSE:GI)
Source:
DateHeadline
biz.yahoo.com logoENDOCHOICE HOLDINGS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting
biz.yahoo.com - November 22 at 5:03 PM
prnewswire.com logoBoston Scientific Closes EndoChoice Acquisition - PR Newswire (press release)
www.prnewswire.com - November 22 at 8:41 AM
finance.yahoo.com logoBoston Scientific Closes EndoChoice Acquisition
finance.yahoo.com - November 22 at 8:41 AM
finance.yahoo.com logoENDOCHOICE HOLDINGS, INC. Financials
finance.yahoo.com - November 16 at 5:29 PM
biz.yahoo.com logoENDOCHOICE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - November 8 at 12:08 AM
prnewswire.com logoBoston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice - PR Newswire (press release)
www.prnewswire.com - November 4 at 10:05 PM
finance.yahoo.com logoBoston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice
finance.yahoo.com - November 4 at 6:41 AM
wsj.com logoBoston Scientific Raises Full-Year Outlook
www.wsj.com - October 27 at 9:52 AM
finance.yahoo.com logo4 Medical Device Stocks on a Bull Run this Earnings Season
finance.yahoo.com - October 26 at 5:16 PM
finance.yahoo.com logoBoston Scientific Announces Results For Third Quarter 2016
finance.yahoo.com - October 26 at 8:20 AM
finance.yahoo.com logoENDOCHOICE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of EndoChoice Holdings, …
finance.yahoo.com - October 8 at 9:49 AM
finance.yahoo.com logoENDOCHOICE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of EndoChoice Holdings, Inc. (GI) Over the Proposed Sale of the Company to Boston Scientific Corporation
finance.yahoo.com - October 8 at 9:49 AM
finance.yahoo.com logoBoston Scientific Commences Cash Tender Offer For All Shares Of EndoChoice For $8.00 Per Share In Cash
finance.yahoo.com - October 7 at 10:11 AM
businesswire.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of EndoChoice Holdings, Inc. And Encourages Investors To Contact The Firm For Additional ...
www.businesswire.com - October 1 at 4:46 PM
businesswire.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of EndoChoice Holdings ... - Business Wire (press release)
www.businesswire.com - September 30 at 5:29 PM

Social

Chart

EndoChoice Holdings (GI) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by MarketBeat.com Staff